Evenamide
Evenamide
Evenamide (pronounced: /ˈɛvənæmaɪd/) is an investigational antipsychotic drug that is currently being studied for its potential use in the treatment of schizophrenia and psychosis related to neurological disorders.
Etymology
The term "Evenamide" is a coined name, with no known etymology.
Pharmacology
Evenamide is a glutamate release inhibitor. It works by modulating the release of glutamate, a neurotransmitter that plays a key role in the pathophysiology of schizophrenia and psychosis. This mechanism of action is different from that of most currently available antipsychotic drugs, which primarily target the dopamine system.
Clinical Trials
Evenamide has been studied in several clinical trials. Preliminary results suggest that it may be effective in reducing the symptoms of schizophrenia and psychosis, particularly in patients who have not responded to other treatments. However, more research is needed to confirm these findings and to determine the optimal dosing and administration of the drug.
Related Terms
External links
- Medical encyclopedia article on Evenamide
- Wikipedia's article - Evenamide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski